Added-Value Generics

Chlorhexidine & Antiseptics

ADDED-VALUE Generics

API

FDF

HPAPI

CHLORHEXIDINE & ANTISEPTICS

API

FDF

Biocide

Pharma

Medichem

MADE WITH CARE

Medichem is a vertically integrated pharmaceutical company. We specialize in the development and manufacture of APIs and FDFs for the global generics industry.

Our portfolio includes around 45 APIs and 20 FDFs, and we are a world leader in Chlorhexidine products. With nearly half a century of industry experience, we guarantee the highest standards of quality, operational excellence and respect for the environment.

Medichem is headquartered in Spain, with a team of over 450 talented individuals in locations including the USA, Malta and China. We serve over 600 corporate customers in more than 60 countries worldwide.

Marketing Authorizations

879

Marketing Authorizations

APIs

44

APIs

Products in
development

28

Products in
development

505(b)(2)
in development

2

505(b)(2)
in development

Years in
operation

50

Years in
operation

Patents and patent applications

68

Patents and patent applications


EXPERTISE

expertise

For half a century, Medichem has been at the forefront of innovation and as such has developed 70 value-added drug products as well as a wide range of services, ranging from R&D to contract manufacturing and licensing.

INNOVATION AND EXCELLENCE
Innovation and Excellence
MANUFACTURING SOLUTIONS
Manufacturing Solutions
REGULATORY & QUALITY
Regulatory & Quality
INTELLECTUAL PROPERTY
Intellectual Property
CONTRACT SERVICES
Contract Services


Worldwide Presence

MALTA

Hal Far

CHINA

Nanjing

CHINA

Anqing

USA

New Jersey

SPAIN

Barcelona

SPAIN

Girona

Worldwide Presence

WORLDWIDE PRESENCE

Medichem Cares

Customer <br> Stories
Environmental  <br>Sustainability
Community <br>Giving

NEWSROOM

Introducing Sugammadex Sodium made by Medichem
16/10/20

Introducing Sugammadex Sodium made by Medichem

Sugammadex Sodium is an injectable solution indicated for the reversal of neuromuscular blockade in anesthesia. Medichem is a v...

Read More
A Policy Roadmap for Medicines Manufacturing Leadership
07/07/20

A Policy Roadmap for Medicines Manufacturing Leadership

As part of our work with @Medicines for Europe, we have developed a policy roadmap for medicines manufacturing in Europe. The #COVID19 c...

Read More
ASIA Q1´20 – Latest Authorizations
22/05/20

ASIA Q1´20 – Latest Authorizations

  Medichem´s DMFs for the Active Pharmaceutical Ingredient of Paroxetine and Rivaroxaban are filed and listed on the CDE website,...

Read More
Corporate Announcement 14.03.2020
14/03/20

Corporate Announcement 14.03.2020

  Dear Customer, Like many of you we have been closely following the developments about coronavirus. At Medichem we deeply care ...

Read More
Q4’19 – Latest Authorizations by the Regulatory Agencies – Asia
20/01/20

Q4’19 – Latest Authorizations by the Regulatory Agencies – Asia

  Medichem receives the Approval Notice Letter by the Korean Authorities for Apixaban´s Active Pharmaceutical Ingredient – Q4’19...

Read More
Medichem Cares, Sustainable Environment
16/12/19

Medichem Cares, Sustainable Environment

Sustainable Environment by Medichem

Read More
Medichem’s R&D and Business Development summit in ESADECREAPOLIS
12/07/19

Medichem’s R&D and Business Development summit in ESADECREAPOLIS

What could be more inspiring than the ESADECREAPOLIS meeting rooms for Medichem's R&D and Business Development summit? On July 9th...

Read More
USP’s Donor Recognition Program would like to recognize Medichem for its contributions…
05/07/19

USP’s Donor Recognition Program would like to recognize Medichem for its contributions…

  "USP’s Donor Recognition Program would like to recognize Medichem for its contributions during the 2018 calendar year" Says Ron...

Read More
“Fostering The Culture of Innovation and Excellence”
05/07/19

“Fostering The Culture of Innovation and Excellence”

  On June 26th, Medichem participated in a Design Thinking Workshop organized by Ship2B. In line with Medichem´s Culture of Inno...

Read More